Key Highlights

Risk & Performance

Pipeline Risk Assessment

Pipeline Risk Assessment

Based on historical performance

Moderate Risk

Score: 35/100

Failure Rate

7.7%

1 terminated/withdrawn out of 13 trials

Success Rate

92.3%

+5.8% vs industry average

Late-Stage Pipeline

8%

1 trials in Phase 3/4

Results Transparency

50%

6 of 12 completed trials have results

Key Signals

6 with results

Enrollment Performance

Analytics

Phase 1
8(61.5%)
Phase 2
4(30.8%)
Phase 3
1(7.7%)
13Total
Phase 1(8)
Phase 2(4)
Phase 3(1)

Activity Timeline

Global Presence

Loading network data...

Clinical Trials (13)

Showing 13 of 13 trials
NCT01400555Phase 1Completed

A Safety Study of Abiraterone Acetate Administered in Combination With Docetaxel in Patients With Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Role: lead

NCT01199146Phase 2Completed

Abiraterone Post Ketoconazole for Prostate Cancer

Role: collaborator

NCT00912899Phase 1Terminated

A Study of Noscapine HCl (CB3304 ) in Patients With Relapsed or Refractory Multiple Myeloma

Role: lead

NCT01088529Phase 2Completed

Neo-adjuvant Abiraterone + Luteinizing Hormone-Releasing Hormone (LHRH) Versus LHRH in Prostate Cancer

Role: lead

NCT00474383Phase 2Completed

An Safety and Efficacy Study of Abiraterone Acetate in Participants With Advanced Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Role: lead

NCT00638690Phase 3Completed

Abiraterone Acetate in Castration-Resistant Prostate Cancer Previously Treated With Docetaxel-Based Chemotherapy

Role: lead

NCT00473512Phase 1Completed

A Safety and Efficacy Study of Abiraterone Acetate in Participants With Prostate Cancer Who Have Failed Hormone Therapy

Role: lead

NCT02001571Phase 1Completed

A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function

Role: lead

NCT00485303Phase 2Completed

An Efficacy and Safety Study of Abiraterone Acetate and Prednisone in Participants With Prostate Cancer Who Failed Androgen Deprivation and Docetaxel-Based Chemotherapy

Role: lead

NCT00600535Phase 1Completed

A Pharmacokinetics Study to Assess Abiraterone Acetate Capsule and Tablet Formulations in Patients With Prostate Cancer

Role: lead

NCT01798628Phase 1Completed

A Study to Determine the Effect of Food on the Pharmacokinetics of Abiraterone Acetate in Healthy Male Patients

Role: lead

NCT01362764Phase 1Completed

A Study to Assess the Relative Bioavailability of Two Abiraterone Acetate Suspension Formulations Compared to the Abiraterone Acetate Tablet Formulation in Healthy Adult Volunteers

Role: lead

NCT01715259Phase 1Completed

A Pharmacokinetic Study of Abiraterone Acetate in Male Participants With Impaired Renal Function Compared to Individuals With Normal Renal Function

Role: lead

All 13 trials loaded